Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Terraxy is a biotechnology and agricultural technology company spun out from the King Abdullah University of Science and Technology (KAUST) that focuses on soil regeneration and desert rehabilitation. The company's flagship technology, SandX, is a nature-inspired, super-water-repellent biodegradable mulch that reduces topsoil water evaporation by up to 80%, significantly enhancing plant health and seedling survivability in arid climates. Terraxy also offers CarboSoil, an engineered biochar produced from organic waste that improves soil fertility, prevents nutrient leaching, and supports carbon sequestration. By combining bioengineering with soil science, Terraxy provides scalable solutions to combat desertification and improve food security in harsh environments. The company has been recognized as a top innovator by the World Economic Forum and has secured funding through the KAUST innovation ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SandX.